Drug development

#Breast cancer #Cancer research #Clinical trial design #Clinical trials #Drug development #Drug discovery #Oncology #Phase III trial

This week in drug discovery (6-10 February)

News round-up for 6-10 February by DDW Digital Content Editor Diana Spencer.  Clinical drug trials have made the headlines this week, as it was revealed that breast cancer still tops the bill for number of clinical studies and the shortcomings in current methods to ensure representation of patient… Read More

#News

Scandinavia
#Drug development #Drug discovery #Life sciences #Market reporting #Scandinavia #Sweden

Scandinavia: insight into opportunities for drug discovery

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. Though not without its challenges, the life sciences industry in Scandinavia… Read More

#Exclusive Content #Market Reports

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Data science #Drug development #Drug discovery #Pharmaceuticals

AI is critical to solving new complexities in drug discovery

Listen to this article on the DDW Podcast: Andrew A Radin Chief Executive Officer of Aria Pharmaceuticals, on the critical use of artificial intelligence in solving some of drug discovery’s most new and complex challenges. Basic research and new technologies are uncovering insights every day that build on… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Learn how to choose the best drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#AAV #Cell and gene therapy #Drug development #Drug discovery #Gene therapy #Immunology / Virology & Vaccines

Optimising AAV capsid purification through improved analytics

Listen to this article on the DDW Podcast: Svea Cheeseman, Refeyn, explains why better efficiency is needed to advance the production of viral vectors for use in gene therapies. Adeno-associated viruses (AAVs) are a promising, widely used vector for delivering gene therapies. As demand for AAV gene… Read More

#Exclusive Content

#Advanced Therapies #Cell and gene therapy #Cell culture #Drug development #Drug discovery #Whitepaper

Whitepaper: From bench to billions in cell and gene therapy

Download our new whitepaper ‘From bench to billions: A guide to facilitating scale-up of adherent cultures for cell and gene therapies’, brought you by Corning. Given the potential of emerging advanced therapies, market demand is likely to continue to grow. Generating the required quantity of cells efficiently becomes even more… Read More

#News

#Advanced Therapies #Cell and gene therapy #Cell culture #Drug development #Drug discovery

From bench to billions: A guide to facilitating scale-up of adherent cultures for cell and gene therapies

Given the potential of emerging advanced therapies, market demand is likely to continue to grow. Generating the required quantity of cells efficiently becomes even more challenging when the cells of interest are attachment-dependent, such as induced pluripotent stem cells (iPSCs). The choice of cell culture platform will have significant operational… Read More

#Resources

ChatGPT
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Computational chemistry #Drug development #Drug discovery #Drug targets #Regulatory #Technology

Four ways ChatGPT could impact drug discovery

It’s impossible to be online and not hear about ChatGPT, the controversial chatbot launched by OpenAI in November 2022. Here, DDW’s Diana Spencer takes a look at the ways ChatGPT and technology like it could change the future of drug discovery and development. Chat Generative Pre-Trained Transformer (or ChatGPT) is… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Bioinformatics #Drug development #Drug discovery #Emmes #Omics #Personalised medicine #Systems biology

How big data analytics can make personalised care a reality

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. A key breakthrough area where big data analytics has shown tremendous scope and application is… Read More

#Exclusive Content #Opinion

#Breast cancer #Cancer research #CAR-T #Drug development #Drug discovery #Immuno-oncology #Lung cancer #Oncology #World Cancer Day

The DDW Highlights Podcast: World Cancer Day 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  As 4 February was World Cancer Day, this week’s update focused on… Read More

#News

Biochemists working in the lab
#Drug development #Drug discovery #Drug Discovery Chemistry #Medicinal chemistry #Research & development

CAS and Torx Software partner to streamline chemistry workflows

Torx Software and CAS, a division of the American Chemical Society, have revealed that they will collbaorate to connect CAS SciFinder users through the Torx platform to streamline workflows for discovery chemistry.   CAS SciFinder is designed to provide solutions to challenges encountered in scientific research and discovery,… Read More

#News

#Cell and gene therapy #Drug development #Drug discovery #Webinar

CGT Webinar: Innovating for the future

On February 17 at 8am PST / 11am EST / 4pm GMT / 5pm CET, join DDW to enjoy this free webinar, Cell and gene therapy: sustaining growth and maximising opportunities. Cell and gene therapies (CGT) are transforming the way diseases are treated. As research progresses it is hoped… Read More

#News

#Antibody #Antibody-based therapeutics #Biotechnology #Drug development #Drug discovery #Genomics #Single-cell analysis

Using single-cell technology to create human antibody-based therapeutics

San Francisco-based biotechnology company Infinimmune is emerging from stealth with its $12 million seed financing. The company is co-founded by former team leaders and multi-disciplinary tool builders from 10x Genomics. Taking a human-first approach, Infinimmune is leveraging single-cell technology to create truly human antibody-based therapeutics directly derived from the… Read More

#Business & Investment #Exclusive Content

#Breast cancer #Cancer research #CAR-T #Drug development #Drug discovery #Immuno-oncology #Lung cancer #Oncology #World Cancer Day

This week in drug discovery (30 January – 3 February)

News round-up for 30 January – 3 February by DDW Digital Content Editor Diana Spencer.  As February 4 is World Cancer Day, this week’s update focuses on developments in the field of oncology. Drugs for lung cancer, lymphoma and breast cancer have received regulatory approvals, an investment boost will … Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

How to choose the most promising drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry

Connected chemistry: How to choose the most promising drug candidates from your hit list

AI and machine learning (AI/ML) methods offer an alluring way to expedite the drug discovery process by delivering a large number of possible new candidates for any given therapeutic area. However, insight from medicinal chemists is still necessary to triage and prioritise the most promising molecules for synthesis, and progress… Read More

Webinar date:
Sponsored by Torx Software
#Webinars